Daniel Patrick O'Day Gilead Sciences, Inc. (GILD) insider trading activity

Daniel Patrick O'Day is Chairman & CEO of GILEAD SCIENCES, INC.. Currently has a direct ownership of 501,528 shares of GILD, which is worth approximately $47.1 Million. The most recent transaction as insider was on Dec 10, 2024, when has been sold 4,762 shares (Common Stock) at a price of $92.34 per share, resulting in proceeds of $439,723. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 502K

1.12% 3M change

29.36% 12M change

Total Value Held $47.1 Million

Daniel Patrick O'Day Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 10 2024	SELL Payment of exercise price or tax liability	$439,723 $92.34 p/Share	4,762 Reduced 0.94%	501,528 Common Stock
Dec 10 2024	BUY Exercise of conversion of derivative security	-	10,295 Added 1.99%	506,290 Common Stock
Sep 10 2024	SELL Payment of exercise price or tax liability	$386,758 $81.44 p/Share	4,749 Reduced 0.95%	495,995 Common Stock
Sep 10 2024	BUY Exercise of conversion of derivative security	-	10,295 Added 2.01%	500,744 Common Stock
Jun 10 2024	SELL Payment of exercise price or tax liability	$306,218 $65.25 p/Share	4,693 Reduced 0.95%	490,449 Common Stock
Jun 10 2024	BUY Exercise of conversion of derivative security	-	10,295 Added 2.04%	495,142 Common Stock
Mar 10 2024	SELL Payment of exercise price or tax liability	$1,035,303 $75.12 p/Share	13,782 Reduced 2.76%	484,847 Common Stock
Mar 10 2024	BUY Exercise of conversion of derivative security	-	29,940 Added 5.66%	498,629 Common Stock
Jan 31 2024	SELL Payment of exercise price or tax liability	$6,208,757 $78.26 p/Share	79,335 Reduced 14.48%	468,689 Common Stock
Jan 31 2024	BUY Grant, award, or other acquisition	-	230,747 Added 29.63%	548,024 Common Stock
Dec 10 2023	SELL Payment of exercise price or tax liability	$264,005 $79.02 p/Share	3,341 Reduced 0.85%	387,691 Common Stock
Dec 10 2023	BUY Exercise of conversion of derivative security	-	7,347 Added 1.84%	391,032 Common Stock
Sep 10 2023	SELL Payment of exercise price or tax liability	$255,816 $76.0 p/Share	3,366 Reduced 0.87%	383,685 Common Stock
Sep 10 2023	BUY Exercise of conversion of derivative security	-	7,348 Added 1.86%	387,051 Common Stock
Jun 10 2023	SELL Payment of exercise price or tax liability	$266,311 $78.12 p/Share	3,409 Reduced 1.26%	266,125 Common Stock
Jun 10 2023	BUY Exercise of conversion of derivative security	-	7,346 Added 2.65%	269,534 Common Stock
Mar 10 2023	SELL Payment of exercise price or tax liability	$1,114,351 $79.5 p/Share	14,017 Reduced 3.6%	375,766 Common Stock
Mar 10 2023	BUY Exercise of conversion of derivative security	-	30,288 Added 7.21%	389,783 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$385,374 $79.59 p/Share	4,842 Reduced 1.33%	359,495 Common Stock
Mar 01 2023	BUY Exercise of conversion of derivative security	-	11,362 Added 3.02%	364,337 Common Stock
Jan 24 2023	SELL Payment of exercise price or tax liability	$4,963,733 $84.02 p/Share	59,078 Reduced 14.34%	352,975 Common Stock
Jan 24 2023	BUY Grant, award, or other acquisition	-	215,017 Added 34.29%	412,053 Common Stock
Dec 10 2022	SELL Payment of exercise price or tax liability	$135,649 $87.97 p/Share	1,542 Reduced 0.6%	254,636 Common Stock
Dec 10 2022	BUY Exercise of conversion of derivative security	-	3,300 Added 1.27%	256,178 Common Stock
Sep 10 2022	SELL Payment of exercise price or tax liability	$99,748 $65.28 p/Share	1,528 Reduced 0.6%	252,878 Common Stock

DPO

Daniel Patrick O'Day

Chairman & CEO

Foster City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GILD shares.

Notify only if

Value

Insider Trading

Get notified when an Gilead Sciences, Inc. insider buys or sells GILD shares.

Notify only if

Operation

Value

Type

News

Receive news related to GILEAD SCIENCES, INC.

Track Activities on GILD

Account